Investigating how RNA and protein processes affect frontotemporal dementia
RNA Surveillance and Protein Translation in FTD
This study is looking at how changes in a specific gene related to frontotemporal dementia can affect brain cells, and it hopes to find new ways to help people with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-10927336 on NIH RePORTER |
What this research studies
This research focuses on frontotemporal dementia (FTD), particularly a form associated with the FUS protein. It aims to understand how mutations in the FUS gene disrupt normal RNA surveillance and protein translation, leading to neuronal loss. The study will utilize both animal models and patient tissues to explore these mechanisms. By examining how these processes are altered in FTD, the research seeks to uncover potential therapeutic targets for this debilitating condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with frontotemporal dementia, especially those with FUS-related mutations.
Not a fit: Patients with forms of dementia unrelated to FUS mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that slow down or prevent neuronal loss in patients with frontotemporal dementia.
How similar studies have performed: Previous research has shown promising results in understanding the role of protein mislocalization in neurodegenerative diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Zhu, Haining — University of Arizona
- Study coordinator: Zhu, Haining
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.